PGP and lung cancer: Hesperetin has also been shown to sensitize cisplatin-resistant human lung cancer cells (A549/DDP) to cisplatin during in vivo and in vitro studies by reducing P-gp expression and increasing intracellular accumulation of P-gp substrates like rhodamine 123 [87].